Tennis elbow breakthrough? study seeks to identify PRP responders

NCT ID NCT07496983

Recruiting now Knowledge-focused Sponsor: Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 139 adults with chronic tennis elbow who recently received a platelet-rich plasma (PRP) injection. Researchers want to find out how many people respond to PRP and what factors—like age, job, or health history—might predict a good outcome. Participants are followed for 90 days with pain and function tests. This is an observational study, not a test of a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LATERAL EPICONDYLITIS OF THE ELBOW are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epicondylitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LATERAL EPICONDYLITIS OF THE ELBOW

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles (CMRRF) de Kerpape
RECRUITING

Ploemeur, 56270, France

Contact Phone: •••-•••-•••• Email: •••••@•••••